AI Drug Discovery
for biotech startups

We are a service integrator leveraging artificial intelligence technologies and a network of partner laboratories to accelerate drug development.

Submit Your Project Proposal
An artist’s illustration of artificial intelligence (AI). This image explores how AI can be used advance biology and protein folding. It was created by Twistedpoly as a single word everywhere as part of the Visualising AI project launched by Google DeepMind.

The Direction
of Disruption

DEEPLAB ANALYTICS is an integrated platform that combines artificial intelligence with leading laboratory resources to accelerate and optimize the drug discovery process. We effectively shorten the time from concept to preclinical trials, enhancing the quality and effectiveness of research.

About Us

Leveraging AI to accelerate research and improve efficiency
Access to a global network of 50+ vetted laboratories worldwide
Centralized coordination of research and real-time data sharing
Efficient management of laboratory supply and logistics
Professional project management focused on quality and timelines
Dashboard mockup
Services

DEEPLAB ANALYTICS employs state-of-the-art artificial intelligence and machine learning methods to process and interpret scientific data

AI Analytics

LabLink AI employs state-of-the-art artificial intelligence and machine learning methods to process and interpret scientific data. Our algorithms help uncover hidden patterns in laboratory results, predict the activity and safety of drug candidates, and optimize the selection of research directions. We integrate diverse datasets (from high-throughput screening to genomics and proteomics) to provide researchers with well-founded insights.

Research Coordination

When it comes to drug discovery and manufacturing, biotechnicians face costly, complex tasks that require immense precision. AI tools can help by standardizing activities such as clinical trials, chemical analysis, and drawing reliable conclusions. This enhances accuracy and reduces inefficiencies across life science business processes.

Supply & Procurement

Pharmaceutical companies are leveraging their vast data archives and advanced analytics to transform drug discovery. By analyzing pooled data, they are gaining new insights into drug synthesis and mechanisms. This enables the development of novel treatments for a wide range of diseases. Powerful AI techniques help unlock the full potential of accumulated R&D data.

Project Management

Beyond fueling scientific discoveries, AI also enables business innovations in biotech. Natural Language Processing helps computers understand complex industry language and concepts. This allows AI systems to reduce friction in pharmaceutical markets by improving search and information discovery for researchers and companies. By streamlining access to specialized knowledge, AI can break down barriers and facilitate efficiency gains that ultimately benefit patients.
Arrow
01
Upper Dot
AI Analytics

LabLink AI employs state-of-the-art artificial intelligence and machine learning methods to process and interpret scientific data.

Research Coordination

Biotechnicians face costly, difficult tasks requiring immense precision.

Upper Dot
02
Arrow
Arrow
03
Lower Dot
Supply & Procurement

Pharmaceutical companies are leveraging their vast data archives and advanced analytics to transform drug discovery.

Project Management

Beyond fueling scientific discoveries, AI also enables business innovations in biotech.

Upper Dot
04

Partner Laboratories

The full expanded list includes more than 50 leading research centers in the US, Europe and Asia participating in the projects
Integration iconIntegration iconIntegration iconIntegration iconIntegration iconIntegration icon

Our suppliers

The full list of suppliers that DEEPLAB ANALYTICS cooperates with includes more than 100 companies
Integration iconIntegration iconIntegration iconIntegration iconIntegration iconIntegration icon

Platforms

Healthcare technology solutions

SciPy

SciPy is a comprehensive library built on top of NumPy, offering additional functionality for scientific and technical computing. It includes modules for optimization, signal processing, statistics, and more, facilitating a wide range of research applications.

OpenBLAS

OpenBLAS is an optimized linear algebra library that accelerates mathematical computations on various CPUs. Its efficient implementation enhances the performance of scientific applications, particularly those involving large-scale matrix operations.

NumPy

NumPy is a fundamental Python library for numerical computations. It provides a robust foundation for array-based operations, mathematical functions, and linear algebra, making it a staple tool for scientific computing and data analysis.

PandaOMICs Data Analysis

PandaOMICs is an AI-powered data analysis platform tailored for omics data, such as genomics and proteomics. It empowers researchers to efficiently process large-scale biological data, uncover meaningful patterns, and make data-driven discoveries.

Chemistry42

Chemistry42 is an AI-driven platform focused on accelerating drug discovery. It employs machine learning and computational chemistry techniques to predict molecular properties, optimize drug candidates, and expedite the process of identifying potential therapies.

AlphaFold

AlphaFold, developed by DeepMind, is a groundbreaking AI system that predicts protein structures with remarkable accuracy. Its deep learning architecture has revolutionized protein folding research, aiding in understanding the functions of various biological molecules.

SpliceCore

SpliceCore is an AI-powered platform designed to analyze RNA sequencing data, with a focus on alternative splicing events. By identifying complex RNA splicing patterns, researchers can gain insights into gene expression regulation and its implications in health and disease.

CZ CELLxGENE Discover

CZ CELLxGENE Discover is a versatile single-cell analysis platform that leverages AI to explore complex cellular landscapes. It helps researchers unravel the heterogeneity of cell populations, uncover novel cell types, and understand cellular interactions within biological systems.

MDAnalysis

MDAnalysis is a Python library dedicated to molecular dynamics simulations analysis. Using this platform, researchers can extract valuable insights from simulations of biomolecular systems, aiding in the study of protein dynamics, interactions, and more.

NAPARI

NAPARI is an interactive, AI-enhanced, multi-dimensional image viewer for Python. It enables researchers to visualize and analyze complex imaging data, facilitating the exploration of intricate biological structures and processes.

Cases

Case 1: First Human Trials of AI-Designed Drugs

Achieve a major milestone in pharmaceutical R&D — initiating clinical trials with drugs entirely designed by artificial intelligence

View more
ArrowArrow
Case 2: AI Discovers a New Antibiotic

Discover a new antibiotic capable of killing drug-resistant bacteria

View more
ArrowArrow
Case 3: AI-Designed Drug for Fibrosis

Develop a new drug for idiopathic pulmonary fibrosis (IPF) using AI.

View more
ArrowArrow
Case 4: AI-Driven Drug Repurposing
(COVID-19)

Quickly find an existing drug that could treat a new disease (COVID-19).

View more
ArrowArrow
Investments

Partnership with Venture Capital and Grant Organizations

Venture Capital

DEEPLAB ANALYTICS actively collaborates with a diverse array of venture capital firms and grant organizations specializing in biotechnology, pharmaceuticals, and medical technology. These partnerships are instrumental in supporting startups and funding innovative developments in the life sciences sector.

Venture Capital Partners maintains strategic relationships with leading venture capital firms that focus on biotech and healthcare innovations:
Chan Zuckerberg Initiative (CZI) – Invests in scalable, impact-driven companies across science, education, and health, including ventures like Citizen Health and the CZ Biohub Network.
Flagship Pioneering – Known for creating and funding groundbreaking biotech companies, including Moderna, with a focus on integrating AI into drug discovery.

Grant Organizations

DEEPLAB ANALYTICS also collaborates with various grant organizations to provide non-dilutive funding opportunities:
National Institutes of Health (NIH) SEED Fund – Supports early-stage biomedical startups through SBIR/STTR grants, fostering innovation in health technologies.
National Science Foundation (NSF) Biological Technologies Program – Offers grants for startups developing cutting-edge biological technologies.
Biomedical Advanced Research and Development Authority (BARDA) – Provides funding for advanced research and development of medical countermeasures.Through these collaborations, DEEPLAB ANALYTICS enhances its ability to support startups and drive innovation in the life sciences sector.

Frequently Ask Questions

What is DEEPLAB and how is it different from regular research service providers?
plusminus
Who can collaborate with DEEPLAB?
plusminus
What types of data do you work with?
plusminus
Do you only analyze data or also offer lab services?
plusminus
How does artificial intelligence help in your work?
plusminus
Can DEEPLAB ANALYTICS help with funding and support?
plusminus

Have an Impressive Project in Mind? Share It With Us

Tell us about your ambitious project by filling out the form below. Whether it’s an innovative idea, a creative venture, or a groundbreaking initiative — we’re excited to hear about it! Let’s bring your vision to life together